Celltrion
068270.KS
#709
Rank
C$40.81 B
Marketcap
$198.56
Share price
3.11%
Change (1 day)
6.89%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$3.58 Billion

According to Celltrion 's latest financial reports the company's total liabilities are C$3.58 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$1.74 B0.09%
2021-12-31C$1.73 B-6.95%
2020-12-31C$1.86 B67.71%
2019-12-31C$1.11 B0.6%
2018-12-31C$1.10 B6.31%
2017-12-31C$1.04 B13.58%
2016-12-31C$0.91 B-17.16%
2015-12-31C$1.10 B7.25%
2014-12-31C$1.03 B14.73%
2013-12-31C$0.89 B37.61%
2012-12-31C$0.65 B46.81%
2011-12-31C$0.44 B33.75%
2010-12-31C$0.33 B33.22%
2009-12-31C$0.25 B-8.62%
2008-12-31C$0.27 B628.66%
2007-12-31C$37.55 M